Aug 01, 2013
1:25
For every 25 shares held, investors received 1.
The split itself did not change the total investment value.
Sorrento Therapeutics, Inc. (SRNE) trades on the Other OTC in the Biotechnology industry.
Sorrento Therapeutics, Inc. company overviewThe latest split shown was on August 1, 2013. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
This history records 3 reverse splits between March 16, 2007 and August 1, 2013.